Clinical Trials Directory

Trials / Unknown

UnknownNCT01577056

Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils

Effect of Fish Oil Supplementation on Postprandial Lipid Metabolism in Familial Hypercholesterolaemia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
The University of Western Australia · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether fish oil supplementation is effective in the treatment of abnormal fat metabolism in subjects with elevated cholesterolaemia.

Detailed description

The use of statin therapy in familial hypercholesterolaemia (FH) is known to reduce cardiovascular risk and is a first line recommendation, however, there is considerable residual risk predicted by the presence of fasting and post-prandial hypertriglyceridaemia. This study will examine the effect of oral n-3 fatty acid ethyl esters supplementation (4g/day, Omacor) on postprandial hypertriglyceridaemia and post-prandial arterial function when administrated to FH patients at increased risk of cardiovascular disease due to their residual fasting hypertriglyceridaemia.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTFish oil capsule4g Omega capsule for 12 weeks
DRUGHMG Coenzyme reductaseAll FH subjects are on standard statin treatment during study period

Timeline

Start date
2012-04-01
Primary completion
2013-12-01
Completion
2014-03-01
First posted
2012-04-13
Last updated
2012-04-13

Locations

1 site across 1 country: Australia

Source: ClinicalTrials.gov record NCT01577056. Inclusion in this directory is not an endorsement.

Postprandial Lipid Metabolism in Familial Hypercholesterolaemia:Effects of Fish Oils (NCT01577056) · Clinical Trials Directory